SELECT MEDICAL HOLDINGS CORP - Common Stock (SEM)

Historical Holders from Q1 2014 to Q1 2025

Symbol
SEM on NYSE
CUSIP
81619Q105
Type / Class
Equity / Common Stock
Shares outstanding
129M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
105M
Holdings value
$1.99B
% of all portfolios
0.001%
Grand Portfolio weight change
+0%
Number of holders
267
Number of buys
156
Number of sells
-126
Average Value change %
0%
Average buys %
+0%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of SELECT MEDICAL HOLDINGS CORP - Common Stock (SEM)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 15.5% $335M 20M BlackRock, Inc. Dec 31, 2024
ORTENZIO ROCCO A 3.2% $68.6M 4.09M Estate of Rocco A. Ortenzio Dec 31, 2024

Institutional Holders of SELECT MEDICAL HOLDINGS CORP - Common Stock (SEM)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 804K $13.4M +$1.15M $16.70 30
2024 Q4 105M $1.99B +$68.8M $18.85 267
2024 Q3 97.9M $3.41B -$76.8M $34.87 282
2024 Q2 99.6M $3.49B +$66.5M $35.06 256
2024 Q1 98.1M $2.96B +$44.6M $30.15 248
2023 Q4 96.4M $2.27B +$37.4M $23.50 239
2023 Q3 96M $2.43B -$50.2M $25.27 241
2023 Q2 97.8M $3.12B -$150M $31.86 219
2023 Q1 101M $2.6B +$18.9M $25.85 210
2022 Q4 99.9M $2.48B +$74.5M $24.83 202
2022 Q3 99M $2.19B -$110M $22.10 200
2022 Q2 99.7M $2.36B -$65.3M $23.62 197
2022 Q1 104M $2.49B -$3.1M $23.99 223
2021 Q4 102M $3.01B -$44.2M $29.40 229
2021 Q3 104M $3.75B -$51.2M $36.17 244
2021 Q2 105M $4.42B +$68.2M $42.26 260
2021 Q1 104M $3.53B +$28.8M $34.10 252
2020 Q4 103M $2.84B +$31.4M $27.66 202
2020 Q3 102M $2.12B -$4.93M $20.82 183
2020 Q2 101M $1.49B -$20.9M $14.73 191
2020 Q1 103M $1.55B -$4.36M $15.00 203
2019 Q4 103M $2.39B -$3.31M $23.34 208
2019 Q3 103M $1.71B -$9.39M $16.57 179
2019 Q2 104M $1.65B +$45.2M $15.87 187
2019 Q1 104M $1.46B -$22.3M $14.09 195
2018 Q4 105M $1.61B -$5.33M $15.35 199
2018 Q3 104M $1.92B +$22.5M $18.40 191
2018 Q2 103M $1.87B +$24.8M $18.15 190
2018 Q1 103M $1.77B +$1.69M $17.25 196
2017 Q4 102M $1.81B +$28.6M $17.65 176
2017 Q3 105M $2.02B +$7.38M $19.20 176
2017 Q2 105M $1.62B -$19.8M $15.35 146
2017 Q1 107M $1.43B +$134M $13.35 156
2016 Q4 110M $1.46B +$7.78M $13.25 150
2016 Q3 110M $1.48B +$30.7M $13.50 154
2016 Q2 107M $1.17B +$3.14M $10.87 166
2016 Q1 107M $1.26B -$9.21M $11.81 149
2015 Q4 107M $1.28B +$42.8M $11.91 156
2015 Q3 105M $1.13B -$27.7M $10.79 157
2015 Q2 104M $1.69B +$66.5M $16.20 174
2015 Q1 102M $1.51B +$57.9M $14.83 156
2014 Q4 96M $1.38B +$50.8M $14.40 156
2014 Q3 95.6M $1.15B +$43.3M $12.03 165
2014 Q2 90.6M $1.41B +$113M $15.60 161
2014 Q1 84.1M $1.05B +$180M $12.45 136